SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of Stock Options Activity

	Twelve months ended December 31, 2020
	Number of options			Weighted average exercise price		Weighted average remaining contractual term		Aggregate Intrinsic Value Price
Outstanding at the beginning of the period		3,110,938		$	2.76		8.23	$	7,579
Granted		952,500			5.18		-		-
Exercised		(626,871	)		2.01		-		-
Forfeited		(146,405	)		3.57		-		-
Outstanding at the end of the period		3,290,162			3.57		7.91		8,768
Exercisable		1,302,349		$	2.79		7.05	$	19,726

Schedule of Recognized Stock-based Compensation

During the twelve months period ended December 31, 2020, the Company recognized compensation expenses related to employees and service providers stock option in the amount of $1,436, as follows:

	Year ended December 31,
	2020		2019
Cost of revenues	$	256	$	134
Research and development	$	393	$	243
Marketing and selling	$	22	$	57
General and administrative	$	765	$	714
	$	1,436	$	1,148